Nicholas A. Saccomano, President and CEO of OnKure Therapeutics, Inc. ($OKUR), sold common shares on the open market five times over the past year, totaling about $3,268. His most recent sale occurred on December 22, 2025. These OKUR insider sales rank 11,456th among 11,678 individual insiders in our database, where the average sale amount is $8.6 million across 6.37 transactions. Saccomano made no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | OnKure Therapeutics, Inc. | $OKUR | Saccomano Nicholas A | President and CEO | A | Employee Stock Option (right to buy) | 330000 | $0.00 | 330,000.0000 | 13,530,892 | 9999.99% | 2.44% |
| March 23, 2026 | OnKure Therapeutics, Inc. | $OKUR | Saccomano Nicholas A | President and CEO | S | Class A Common Stock | 86 | $4.16 | 7,333.0000 | 13,530,892 | 1.16% | 0.00% |
| Dec. 22, 2025 | OnKure Therapeutics, Inc. | $OKUR | Saccomano Nicholas A | President and CEO | S | Class A Common Stock | 87 | $2.97 | 7,419.0000 | 13,530,892 | 1.16% | 0.00% |
| Sept. 22, 2025 | OnKure Therapeutics, Inc. | $OKUR | Saccomano Nicholas A | President and CEO | S | Class A Common Stock | 88 | $2.62 | 3,506.0000 | 3,447,071 | 2.45% | 0.00% |
| June 23, 2025 | OnKure Therapeutics, Inc. | $OKUR | Saccomano Nicholas A | President and CEO | S | Class A Common Stock | 88 | $2.38 | 3,594.0000 | 3,447,071 | 2.39% | 0.00% |
| April 7, 2025 | OnKure Therapeutics, Inc. | $OKUR | Saccomano Nicholas A | President and CEO | S | Class A Common Stock | 516 | $2.67 | 3,682.0000 | 3,447,071 | 12.29% | 0.01% |
| April 4, 2025 | OnKure Therapeutics, Inc. | $OKUR | Saccomano Nicholas A | President and CEO | S | Class A Common Stock | 358 | $3.33 | 4,198.0000 | 3,447,071 | 7.86% | 0.01% |
| Jan. 27, 2025 | OnKure Therapeutics, Inc. | $OKUR | Saccomano Nicholas A | President and CEO | A | Employee Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 3,447,071 | 9999.99% | 3.77% |
| Oct. 4, 2024 | OnKure Therapeutics, Inc. | $OKUR | Saccomano Nicholas A | President and CEO | A | Employee Stock Option (right to buy) | 8449 | $0.00 | 8,449.0000 | 316,142 | 9999.99% | 2.67% |
| Oct. 4, 2024 | OnKure Therapeutics, Inc. | $OKUR | Saccomano Nicholas A | President and CEO | A | Employee Stock Option (right to buy) | 2359 | $0.00 | 2,359.0000 | 316,142 | 9999.99% | 0.75% |
| Oct. 4, 2024 | OnKure Therapeutics, Inc. | $OKUR | Saccomano Nicholas A | President and CEO | A | Class A Common Stock | 4556 | $0.00 | 4,556.0000 | 316,142 | 9999.99% | 1.44% |
| Oct. 4, 2024 | OnKure Therapeutics, Inc. | $OKUR | Saccomano Nicholas A | President and CEO | A | Employee Stock Option (right to buy) | 542232 | $0.00 | 542,232.0000 | 316,142 | 9999.99% | 100.00% |
| Oct. 4, 2024 | OnKure Therapeutics, Inc. | $OKUR | Saccomano Nicholas A | President and CEO | A | Employee Stock Option (right to buy) | 1485 | $0.00 | 1,485.0000 | 316,142 | 9999.99% | 0.47% |
| Oct. 4, 2024 | OnKure Therapeutics, Inc. | $OKUR | Saccomano Nicholas A | President and CEO | A | Employee Stock Option (right to buy) | 16898 | $0.00 | 16,898.0000 | 316,142 | 9999.99% | 5.35% |